Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Tucatinib for Metastatic Breast Cancer
Recruiting1 awardPhase 2
Middletown, New Jersey
This trial studies tucatinib in people with HER2+ cancer that has spread to the brain, to learn more about how cancer cells can develop resistance to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service